Publication | Open Access

The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of in silico methods for treatment of COVID-19

Novel TherapyMedicineAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyNovel InhibitorsSilico MethodsAntiviral DrugPharmacologyMain ProteaseDrug DiscoveryCovid-19